Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herceptin + Chemotherapy in Neoadjuvant Operable Breast Cancer
NCT00038402Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2001
- Primary completion
- Nov 2004
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2001; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00038402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038402.